Pharmaceuticals.jpg

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

139272-67-6

Aceclofenac Ethyl Ester

139272-67-6
123-99-9

Azelaic acid

123-99-9
765927-71-7

Azitromycin impurete M

765927-71-7
59277-89-3

Acyclovir

59277-89-3
23313-12-4

Ascorbate-2-phosphate

23313-12-4
858956-08-8

Aminocyclopyrachlor

858956-08-8
549-18-8

Amitryptyline HCl

549-18-8
71675-85-9

Amisulpride

71675-85-9
63-05-8

4-androstène-3,17-dione

63-05-8
315-30-0

Allopurinol

315-30-0
81346-71-6

Atenolol-desisopropyl

81346-71-6
3598-37-6

Acepramazine maleate

3598-37-6
344423-98-9

Atorvastatin calcium salt 3H2O

344423-98-9
83-15-8

4-Acetamidoantipyrin

83-15-8
83-07-8

4-Aminoantipyrine

83-07-8
22568-64-5

Acebutolol impurity B

22568-64-5
1563-56-0

2-(2-Amino-5-bromobenzoyl)pyridine

1563-56-0
99-92-3

4-aminoacetophenone

99-92-3
60-31-1

Acetylcholine Chloride

60-31-1
19774-82-4

Amiodarone HCl

19774-82-4